Sign in
4

Changes in Ownership

Yarrow Bioscience, Inc. Filed Acc 0001209191-20-020663

Options or other derivatives

  • Director acquired 45,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Sandoval Elisabeth · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-03-19 Grant or award : show line 1 in the form Stock Option +45,000 $2.67 2030-03-19 45,000 45,000 D
Loading xslF345X03/doc4.xml…